(Q51910603)

17 April 2018

title

Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy. (English)

1 reference

17 April 2018

author name string

Weintraub D

1

1 reference

17 April 2018

Buchsbaum R

2

1 reference

17 April 2018

Resor SR Jr

3

1 reference

17 April 2018

Hirsch LJ

4

1 reference

17 April 2018

publication date

31 October 2006

1 reference

17 April 2018

published in

Epilepsy Behavior

1 reference

17 April 2018

volume

10

1 reference

17 April 2018

issue

1

1 reference

17 April 2018

page(s)

105-110

1 reference

17 April 2018

Behavioural effects of the newer antiepileptic drugs: an update

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.08.008

Psychiatric syndromes related to antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.08.008

Effects of antiepileptic medications on psychiatric and behavioral comorbidities in children and adolescents with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.08.008

Cognitive and behavioural assessments in clinical trials: what type of measure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.08.008

New antiepileptic drugs: comparison of key clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.08.008

Adverse reactions to new anticonvulsant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.08.008

A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.08.008

Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.08.008

Psychiatric adverse events during levetiracetam therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.08.008

A Double-Blind, Randomized, Placebo-Controlled Trial of Augmentation With Lamotrigine or Placebo in Patients Concomitantly Treated With Fluoxetine for Resistant Major Depressive Episodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.08.008

Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.08.008

Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.08.008

Topiramate and psychiatric adverse events in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.08.008

Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.08.008

Psychiatric issues in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.08.008

10.1016/J.YEBEH.2006.08.008

7 January 2021

Identifiers

DOI

1 reference

17 April 2018

1 reference

17 April 2018